InsiderTrades

Form 4 for ALKS Alkermes plc.

Accepted 2025-02-28 00:00:00 ET · period of report 2025-02-26 · accession 0001127602-25-007313 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-28 2025-02-26 ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off F - Tax $34.80 -3,049 77.7K -4% -$106.1K
D 2025-02-28 2025-02-26 ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off M - OptEx — +6,866 80.8K +9% —
D 2025-02-28 2025-02-26 ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off M - OptEx — -6,866 20.6K -25% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2025-02-26 F D 3,049 $34.80 77,740 D — —
2 Common Ordinary Shares 2025-02-26 M A 6,866 — 80,789 D — — (F1) Each restricted stock unit represents a contingent right to receive one ordinary share.
3 Derivative Restricted Stock Unit Award 2025-02-26 M D 6,866 — 20,598 D — · — to — 6,866 Ordinary Shares (F1) Each restricted stock unit represents a contingent right to receive one ordinary share. (F2) Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025.